Pim-1 Kinase Stability is Regulated by Heat Shock Proteins and the Ubiquitin-proteasome Pathway
Overview
Affiliations
Elevated expression of the serine/threonine kinase Pim-1 increases the incidence of lymphomas in Pim-1 transgenic mice and has also been found to occur in some human cancers. Pim-1 acts as a cell survival factor and may prevent apoptosis in malignant cells. It was therefore of interest to understand to what extent maintenance and degradation of Pim-1 protein is affected by heat shock proteins (Hsp) and the ubiquitin-proteasome pathway in K562 and BV173 human leukemic cells. The half-life of Pim-1 protein in these cells was found to increase from 1.7 to 3.1 hours when induced by heat shock or by treating the cells with the proteasome inhibitor PS-341 (bortezomib). The Hsp90 inhibitor geldanamycin prevented the stabilization of Pim-1 by heat shock. Using immunoprecipitation, it was determined that Pim-1 is targeted for degradation by ubiquitin and that Hsp70 is associated with Pim-1 under these circumstances. Conversely, Hsp90 was found to protect Pim-1 from proteasomal degradation. A luminescence-based kinase assay showed that Pim-1 kinase bound to Hsp70 or Hsp90 remains active, emphasizing the importance of its overall cellular levels. This study shows how Pim-1 levels can be modulated in cells through degradation and stabilization.
PIM1 kinase and its diverse substrate in solid tumors.
Choudhury R, Bahadi C, Ray I, Dash P, Pattanaik I, Mishra S Cell Commun Signal. 2024; 22(1):529.
PMID: 39487435 PMC: 11531143. DOI: 10.1186/s12964-024-01898-y.
PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target.
Yang X, Liu C, Lei Y, Liu Z, Zhu B, Zhao D Front Immunol. 2024; 15:1443784.
PMID: 39372407 PMC: 11449710. DOI: 10.3389/fimmu.2024.1443784.
Alem F, Brahms A, Tarasaki K, Omole S, Kehn-Hall K, Schmaljohn C Front Cell Infect Microbiol. 2024; 14:1331755.
PMID: 38800833 PMC: 11127626. DOI: 10.3389/fcimb.2024.1331755.
PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides.
Assirelli E, Ciaffi J, Scorcu V, Naldi S, Brusi V, Mancarella L Int J Mol Sci. 2024; 25(6).
PMID: 38542097 PMC: 10969826. DOI: 10.3390/ijms25063123.
PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
Torres-Ayuso P, Katerji M, Mehlich D, Lookingbill S, Sabbasani V, Liou H Cell Chem Biol. 2023; 31(2):326-337.e11.
PMID: 38016478 PMC: 10922308. DOI: 10.1016/j.chembiol.2023.10.023.